Table 1 Body mass (BM), absolute (Fm1LH) and relative (Frelm1LH) maximal voluntary ground reaction force, serum inflammatory markers and pQCT-derived values adjusted for BM of women with different body fat percentage
<30% body fat (n=19) | 30–40% body fat (n=21) | >40% body fat (n=24) | |
|---|---|---|---|
Mechanical factors | |||
BM (kg) | 61.6±7.6 | 73.9±8.7*** | 88.4±11.4***,### |
Fm1LH (N) | 1999±298 | 2199±360 | 2274±318* |
Frelm1LH | 3.33±0.28 | 3.05±0.30* | 2.63±0.31*,### |
Non-mechanical factors | |||
CRP (mg dl−1) | 1.38±1.27 | 3.11±3.37 | 5.82±5.94** |
AGP (g l−1) | 0.74±0.18 | 0.84±0.19 | 1.05±0.26***,## |
IL-6 (pg ml−1) | 0.86±0.68 | 0.81±0.55 | 1.30±0.68# |
pQCT-derived variables | |||
vBMC4% (g cm−1 kg−1 BM) | 0.0559±0.0062 | 0.0455±0.0041*** | 0.0388±0.0054***,### |
vBMD.tb4% (mg cm−3 kg−1 BM) | 4.12±0.64 | 3.36±0.47*** | 2.85±0.63***,# |
vBMD.tot4% (mg cm−3 kg−1 BM) | 5.14±0.75 | 4.16±0.51*** | 3.59±0.71***,# |
Ar.bone.tb4% (mm2 kg−1 BM) | 8.07±0.81 | 6.76±0.75*** | 5.64±0.58***,### |
Ar.bone.tot4% (mm2 kg−1 BM) | 17.9±1.8 | 15.0±1.7*** | 12.5±1.3***.### |
vBMC14% (g cm−1 kg−1 BM) | 0.0408±0.0039 | 0.0344±0.0035*** | 0.0291±0.0032***,### |
vBMD.ct14% (mg cm−3 kg−1 BM) | 18.1±2.1 | 15.0±1.9*** | 12.8±1.7***,## |
vBMD.tot14% (mg cm−3 kg−1 BM) | 8.97±1.49 | 7.47±1.36** | 6.22±1.13***,## |
Ar.bone.ct14% (mm2 kg−1 BM) | 2.71±0.29 | 2.24±0.24*** | 1.90±0.23***,### |
Ar.bone.tot14% (mm2 kg−1 BM) | 7.54±0.81 | 6.39±0.78*** | 5.43±0.63***,### |
SSIPOL14% (mm3 kg−1 BM) | 24.0±2.4 | 19.9±3.4*** | 17.4±2.4***,# |
vBMC38% (g cm−1 kg−1 BM) | 0.0546±0.0049 | 0.0468±0.0048*** | 0.0405±0.0039***,### |
vBMD.ct38% (mg cm−3 kg−1 BM) | 19.1±2.3 | 15.7±2.0*** | 13.3±1.7***,### |
vBMD.tot38% (mg cm−3 kg−1 BM) | 14.6±1.8 | 12.1±1.7*** | 10.3±1.5***,## |
Ar.bone.ct38% (mm2 kg−1 BM) | 4.35±0.40 | 3.76±0.41*** | 3.22±0.31***,### |
Ar.bone.tot38% (mm2 kg−1 BM) | 6.14±0.43 | 5.34±0.57*** | 4.53±0.42***,### |
SSIPOL38% (mm3 kg−1 BM) | 23.5±2.5 | 20.6±2.8** | 17.4±2.5***,### |